Giuseppina Ortu

Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase

Thomas A. Bonasera, Giuseppina Ortu, Yulia Rozen et al. · Nuclear Medicine and Biology · 2001 · 89 citations

Life Sciences, Biochemistry, Molecular Biology +11

Neglected tropical diseases: exploring long term practical approaches to achieve sustainable disease elimination and beyond

Giuseppina Ortu, Oliver F. Williams · Infectious Diseases of Poverty · 2017 · 75 citations · Full text

Public Health, Community Health, Infectious Diseases +17

Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis

Conrad Muzoora, Kabanda Taseera, Giuseppina Ortu et al. · Journal of Infection · 2011 · 73 citations

Medicine, Infectious Diseases, Microbiology +14

Labeled EGFr‐TK irreversible inhibitor (ML03): <i>In vitro</i> and <i>in vivo</i> properties, potential as PET biomarker for cancer and feasibility as anticancer drug

Giuseppina Ortu, Iris Ben‐David, Yulia Rozen et al. · International Journal of Cancer · 2002 · 66 citations

Medicine, Oncology, Pharmacology +17

Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans

Giuseppina Ortu, Sandra Mounier‐Jack, Richard Coker · Health Policy and Planning · 2008 · 63 citations · Full text

Planning, Emergency Preparedness, Infectious Diseases +17